At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
Longer Zilver PTX Stents +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Zilver PTX Drug-Eluting Peripheral Stent
In Brief
A clinical study evaluating Longer Zilver PTX Stents and Shorter Zilver PTX Stents for Peripheral Arterial Disease. Completed, enrolled 45 participants across 4 sites in 2 countries.
Detailed Summary
This randomized, post-market clinical study is intended to evaluate the delivery and deployment of longer Zilver PTX stents (≥ 100 mm) compared to shorter Zilver PTX stents (≤80 mm) for treatment of lesions of the above-the-knee femoropopliteal artery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesGermany, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2011
First PostedMay 2011
Primary CompletionOct 2011
Study CompletionSep 2012
TodayJul 2026
First PostedMay 5, 2011
Enrollment StartMay 1, 2011
Primary CompletionOct 1, 2011
Study CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 15.2 years ago
Interventions
Longer Zilver PTX Stentsdevice
Treatment with at least one 100 mm or longer Zilver PTX stent
Shorter Zilver PTX Stentsdevice
Treatment with Zilver PTX stents 80 mm or shorter only